User:Tkadm30/Notebook/Loxapine: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
(New page: === Drug delivery of loxapine for schizophrenia === * Atypical antipsychotic evidences * Tetracyclic antipsychotic with "antidepressant" properties (metabolize amoxapine) <cite>Wikipedia...)
 
No edit summary
Line 1: Line 1:
=== Drug delivery of loxapine for schizophrenia ===
=== Drug delivery of loxapine for schizophrenia ===
* Atypical antipsychotic evidences
* Atypical antipsychotic evidences <cite>Glazer</cite>
* Tetracyclic antipsychotic with "antidepressant" properties (metabolize amoxapine) <cite>Wikipedia</cite>
* Tetracyclic antipsychotic with "antidepressant" properties (metabolize amoxapine) <cite>Wikipedia</cite>
* inhalable drug
* inhalable drug
* clozapine-like functional and structural homology <cite>PMC1188731</cite>


=== References ===
=== References ===
<biblio>
<biblio>
# Wikipedia http://en.wikipedia.org/wiki/Loxapine
# Wikipedia http://en.wikipedia.org/wiki/Loxapine
# PMC1188731 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188731/
# Glazer pmid=10340686
</biblio>
</biblio>

Revision as of 06:45, 30 December 2014

Drug delivery of loxapine for schizophrenia

  • Atypical antipsychotic evidences [1]
  • Tetracyclic antipsychotic with "antidepressant" properties (metabolize amoxapine) [2]
  • inhalable drug
  • clozapine-like functional and structural homology [3]

References

  1. Glazer WM. Does loxapine have "atypical" properties? Clinical evidence. J Clin Psychiatry. 1999;60 Suppl 10:42-6. PubMed ID:10340686 | HubMed [Glazer]
  2. [Wikipedia]
  3. [PMC1188731]